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Conformational analysisdrug and lipids may be critical for the pharmacological activity. We previously
showed that the ability of a ﬂuoroquinolone antibiotic, ciproﬂoxacin, to induce disorder and modify the
orientation of the acyl chains is related to its propensity to be expelled from a monolayer upon compression
[1]. Here, we compared the binding of ciproﬂoxacin on DPPC and DPPG liposomes (or mixtures of
phospholipids [DOPC:DPPC], and [DOPC:DPPG]) using quasi-elastic light scattering and steady-state
ﬂuorescence anisotropy. We also investigated ciproﬂoxacin effects on the transition temperature (Tm) of
lipids and on the mobility of phosphate head groups using Attenuated Total Reﬂection Fourier Transform
Infrared-Red Spectroscopy (ATR-FTIR) and 31P Nuclear Magnetic Resonance (NMR) respectively. In the
presence of ciproﬂoxacin we observed a dose-dependent increase of the size of the DPPG liposomes whereas
no effect was evidenced for DPPC liposomes. The binding constants Kapp were in the order of 105 M−1 and the
afﬁnity appeared dependent on the negative charge of liposomes: DPPGNDOPC:DPPG (1:1; M:M)N
DPPCNDOPC:DPPC (1:1; M:M). As compared to the control samples, the chemical shift anisotropy (Δσ)
values determined by 31P NMR showed an increase of 5 and 9 ppm for DPPC:CIP (1:1; M:M) and DPPG:CIP
(1:1; M:M) respectively. ATR-FTIR experiments showed that ciproﬂoxacin had no effect on the Tm of DPPC
but increased the order of the acyl chains both below and above this temperature. In contrast, with DPPG,
ciproﬂoxacin induced a marked broadening effect on the transition with a decrease of the acyl chain order
below its Tm and an increase above this temperature. Altogether with the results from the conformational
analysis, these data demonstrated that the interactions of ciproﬂoxacin with lipids depend markedly on the
nature of their phosphate head groups and that ciproﬂoxacin interacts preferentially with anionic lipid
compounds, like phosphatidylglycerol, present at a high content in these membranes.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The introduction of ﬂuoroquinolones, such as ciproﬂoxacin, more
than 20 years ago offered clinicians a range of antimicrobial agents that
have a broad spectrum of activity [2] together with an activity against
several intracellular bacteria [3]. The central structural unit of
ciproﬂoxacin (Fig. 1) is a quinolone ring with a ﬂuorine atom at the
6-position, a piperazine moiety at the 7-position, a cyclopropyl ring at
position 1 and a carboxyl group at position 3. The primary mechanism
of action of these compounds involves inhibition of the intracellular
DNA gyrase and topoisomerase IV [4]. Before they can exert their
antibacterial effect, ﬂuoroquinolones must enter bacterial cells. While2 2 764 73 73.
eot-Leclercq).
l rights reserved.the outer membrane protein F (OmpF) plays an important role in the
uptake of ﬂuoroquinolones for Gram-negative bacteria togetherwith a
direct uptake by a lipidmediated pathway [5], the passage through the
phospholipid bilayer is themajor process involved for innermembrane
of Gram-negative bacteria andmembrane of Gram-positive organisms
[6]. For their intracellular activity, ﬂuoroquinolones have also to
penetrate into cells and to accumulate within. Diffusion and efﬂux
processes modulate this cellular accumulation [7–9].
With respect to the interactions of ciproﬂoxacin with lipids, it has
been established that ciproﬂoxacin had a small but deﬁnite and
measurable interaction with neutral and charged membranes at the
headgroup region [10]. The binding appeared as the result of (i)
hydrophobic forces between the lipid bilayer and ciproﬂoxacin [11–13]
and (ii) an ionic interaction between negatively charged phosphate
groups of the phospholipid and the positively charged piperazine ring
at the C-7 position of the quinolone [12–14].
Fig. 1. Structural formula of ciproﬂoxacin (1-cyclopropyl-6-ﬂuoro-1,4-dihydro-4-oxo-7-
(1-piperazinyl)-3-quinolinecarboxylic acid).
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interaction between ciproﬂoxacin and lipids, we previously showed
[1] in the presence of this antibiotic (i) the erosion of DPPC domains in
the DOPC ﬂuid phase as demonstrated by AFM, (ii) the shift of the
surface pressure area—isotherms of DOPC:DPPC:ciproﬂoxacin mono-
layer towards the lower area per molecule as evidenced by Langmuir
studies, and (iii) the decrease of the all-trans conformation of acyl lipid
chains of DPPC together with a change of their orientation measured
using ATR-FTIR.
Unfortunately, only few data [6,15] are available to compare the
interaction of ﬂuoroquinolones with both zwitterionic (DPPC) and
negatively charged (DPPG) lipids in terms of their binding parameters
together with the effect of the drugs on the dynamics of these lipids.
Moreover, consequences of this interaction on temperature-depen-
dent parameters such as the disorder of the hydrophobic tails of the
lipids representing the major components of mammalians and
bacterial membranes are still largely unexplored. Such information
is however critical since the lipid composition of both bacterial and
eukaryotic membranes markedly differs [16]. The bacterial plasmatic
membrane mainly consists of a high amount of anionic lipids like
phosphatidylglycerol whereas the membrane of eukaryotic cells
appear uncharged and consisting almost exclusively of zwitterionic
lipids, like phosphatidylcholine [17].
In this work, using DPPC, a zwitterionic lipid, and DPPG, an anionic
lipid, mimicking the bulk lipid of eukaryotic membranes and the
major component of bacterial membranes respectively, we therefore
turned our efforts (i) to determine the binding parameters of
ciproﬂoxacin to lipids using steady-state ﬂuorescence anisotropy, (ii)
to characterize the effect of the drug on the structure and dynamics of
multilamellar vesicles using 31P NMR and (iii) to follow, the inﬂuence
of ciproﬂoxacin on the acyl chain order as a function of temperature,
using ATR-FTIR. Results were related to the location of ciproﬂoxacin at
the hydrophilic/hydrophobic interface, to the mean surface occupied
by each DPPC and DPPG molecules in the presence and in the absence
of ciproﬂoxacin, and to the energy of interaction between ciproﬂox-
acin and DPPC or DPPG, as determined by molecular modeling.
2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidyl glycerol (DPPG), dipalmitoylphosphati-
dylcholine (DPPC) and dioleoylphosphatidylcholine (DOPC) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA) and stored
at −20 °C. Ciproﬂoxacin (1-cyclopropyl-6-ﬂuoro-1,4-dihydro-4-oxo-7-
(1-piperazinyl)-3-quinoline carboxylic acid) was supplied as hydro-chloride salt (Mw=367.85 g/mol; microbiological standard potency,
85.5%) by Bayer Healthcare AG (Leverkusen, Germany). Stock solutions
were prepared in 10 mM Tris (pH 7.4).
2.2. Methods
2.2.1. Preparation of liposomes (MLVs, LUVs)
The large unilamellar vesicles (LUVs) consisting of DPPG, DOPC:
DPPG (1:1; M:M), DOPC:DPPC (1:1; M:M), or DPPC were prepared as
follows. Lipids were mixed in chloroform:methanol (2:1; V:V),
evaporated under nitrogen ﬂow and dessicated under vacuum
overnight to remove any residual solvent. The dried ﬁlms were then
resuspended at 40 °C from the walls of the glass tube by vigorous
vortexing either in Tris:NaCl buffer 10:100 mM (pH 7.4) for binding
experiments, or 10 mM Tris (pH 7.4) for binding stoechiometry, ATR-
FTIR and 31P NMR studies. Multilamellar vesicles (MLVs) were
obtained by ﬁve heat-cooled cycles. Large unilamellar vesicles
(LUVs) were then prepared by extrusion (ten times) of the MLV
suspension through 100 nm of diameter polycarbonate ﬁlters
(Nucleopore Costar Corporation, Badhoevedorp, Netherlands), using
a thermostated (40 °C) extruder (Lipex Biomembranes, Vancouver,
Canada). The actual phospholipid content of each preparation was
determined by phosphorus assay [18] and the concentration of
liposomes was adjusted for each experiment.
2.2.2. Quasi-elastic light scattering measurements
The apparent average diameter of the LUVs and MLVs and the zeta
potential of LUVs were determined using a Zetasizer (Zen 3600,
Malvern Instruments, U.K.) with the following speciﬁcations: 60 s
sampling time; 0.8872 cP medium viscosity; 1.33 refractive index; 90°
scattering angle; 25 °C temperature. Data were analyzed using the
multimodal number distribution software included in the instrument
for size determinations. The zeta potential values were calculated
using Helmholtz–Smoluchowski's equation. All the measurements
were performed using liposomes at a concentration of 0.5 mg/ml.
2.2.3. Steady-state ﬂuorescence anisotropy
Fluorescence anisotropy is a powerful technique for investigating
macromolecular dynamics, in which the sample is excited by linearly
polarized light. The anisotropy was evaluated by observing the
ﬂuorescence at polarizations parallel (I||) and perpendicular (I?) to the
excitation according to:
r = IO−I?ð Þ= IO + 2I?ð Þ: ð1Þ
The anisotropy titrations of LUV liposomes by ciproﬂoxacin were
performed with a ﬂuorescence spectrophotometer (Perkin Elmer LS-
55, Beaconsﬁeld, U.K.) in the T-format at 25 °C, by adding increasing
concentrations of liposomes to a ﬁxed amount of antibiotic (5 μM).
Anisotropy measurements were performed every 20 s during 4 min.
The emitted light was monitored through 390 nm interference ﬁlters.
Excitation and emission bandwidths were both 9 nm. The excitation
and emission wavelengths were set at 280 nm and 430 nm,
respectively. The Scatchard equation was rewritten (Eq. 2) to directly
ﬁt the anisotropy r, as described previously [19]
r = r0−
r0−rtð Þ
Lt
1 + Lt + nNtð ÞKapp
 2−
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where, r0 and r correspond to the anisotropy of the ciproﬂoxacin in
the absence and in the presence of a given concentration of the LUV
liposomes. Lt and Nt designate the concentration of ciproﬂoxacin ﬁxed
at 5 μM and the concentration of lipids in LUV liposomes added,
respectively. rt is the anisotropy at the plateau value. Kapp and n
correspond to the apparent binding constant and the number of
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2.2.4. 31P nuclear magnetic resonance (NMR)
The effect of ciproﬂoxacin on the mobility of phosphate headgroups
of DPPC and DPPG prepared as MLV was investigated by static 31P NMR
experiments. For a nonspherical charge distribution about the phos-
phorous nucleus, the shielding constant largely results from a local
diamagnetic shielding contribution and a local paramagnetic shielding
contribution. Because the charge distribution in a phosphorusmolecule
will be far from spherically symmetrical, the major contribution to the
31P chemical shift comes from theparamagnetic term. Asymmetry in the
charge distribution implies that the 31P chemical shifts (or shielding
constants) vary as a function of the orientation of the molecule relative
to the external magnetic ﬁeld. This gives rise to a chemical shift
anisotropy (Δσ) which can be deﬁned by three principal components
σ11, σ22 and σ33 of the shielding tensor and which is a frequently used
parameter to characterize the 31P NMR spectra. Formolecules which are
axially symmetrical, with σ11 along the principal axis of symmetry,
σ11=σ‖ (parallel component), and σ22=σ33=σ⊥ (perpendicular compo-
nent). The 31P chemical shift anisotropy is sensitive to both headgroup
geometry and local dynamics. Rapid motion with limited amplitude
along the molecular axis of the phospholipid normal to the membrane
produces a supplementary averaging of the anisotropy tensor. The
effective tensor still has axial symmetry but the chemical shift
anisotropy is reduced. When 1H decoupling is applied, 31P spectra are
obtained that result solely from the chemical shift anisotropy. The
chemical shift anisotropy can be measured by taking the difference of
chemical shift between the low ﬁeld shoulder (σ‖) and the high-ﬁeld
peak (σ⊥): Δσ=σ ‖ − σ⊥ [20].
Control samples of 450 μl were prepared from MLV suspension
(50 mg/ml) in 5 mm outer diameter tubes, by adding 50 μl of D2O for
locking on the deuterium signal. To investigate the effect of the
ciproﬂoxacin on the mobility of lipid (DPPC and DPPG) headgroups, a
deﬁned concentration of drug was added to MLV liposomes to reach a
molar ratio of one.
Broadband proton-decoupled 31P NMR spectra were acquired by
1D NMR methods on a Bruker AVANCE 500 spectrometer at
202.5 MHz (11.7 Tesla) equipped with a Bruker 5 mm BBI (broad
band inverse) probe. Typical Fourier transform spectral parameters
were: 45° (6 μs) ﬂip angle, 50 kHz spectral width, 8K data points, 0.6 s
repetition time. Sixty thousands transients were accumulated. An
exponential multiplication corresponding to 70 Hz line broadening
was applied to the free induction decay prior to Fourier transforma-
tion. All chemical shift values were quoted in parts per million (ppm)
and were referenced to the isotropic chemical shift of H3PO4 (0 ppm).
All spectra were recorded at a constant temperature of 45 °C.
2.2.5. Infrared spectroscopy
Attenuated Total Reﬂection Fourier Transform Infra-Red (ATR-
FTIR) is particularly well suited for the study of membranes and to
characterize the effect of drugs on melting temperature [21]. This
technique is based on internal reﬂection of the infrared light within an
internal reﬂection germanium plate, which creates an evanescent ﬁeld
at the surface of the plate where the lipid bilayer (and eventually the
bound proteins or drugs) resides [22].
The internal reﬂection element was a 52×20×2 mm trapezoidal
germanium ATR plate (ACM, Villiers St Frédéric, France) with an
aperture angle of 45° yielding 25 internal reﬂections. 10 μl of the
sample containing DPPC or DPPG liposomes (50 mg/ml in Tris buffer
10mM, pH 7.4) was dried under a stream of nitrogen on one side of the
germanium internal reﬂection element at 20 °C. Under these
conditions a well ordered multilayer stack is formed [23] and the
stack is stable under a buffer ﬂow [24]. The ciproﬂoxacinwas added to
the lipids at a ratio 1:1 as suggested by the stoechiometry binding
experiments.The germanium crystal was then placed in an ATR holder for liquid
samples with an in- and out-let (Harrick, Ossining, NY, USA). The liquid
cell was placed at 45 incidence on a Specac vertical ATR setup. The
temperature was controlled with temperature-regulated water ﬂowing
in a cavity of the steal cell. The temperaturewas raised degree by degree.
An elevator under computer control made it possible to move the
whole setup along a vertical axis (built for us by WOW Company SA,
Nannine, Belgium). This allowed the crystal to be separated in
different lanes. Here, one such lane contained the membrane ﬁlm,
the other was used for the background.
IR Spectra were obtained on a Bruker IFS55 FTIR spectrometer
(Ettlingen, Germany) purged with N2 as described previously [25].
Brieﬂy, typically interferograms were recorded with 2 cm−1 spectral
resolution with broadband MCT detector between 4000–800 cm−1,
128 scans were averaged for one spectrum.
The spectra were corrected from the water vapor and CO2
contributions. They were then apodized in the Fourier domain in
order to yield a ﬁnal resolution of 4 cm−1. Peak positions were
determined according to a classical peak picking method. All the
software used for data processing was written under MatLab 6.5
(Mathworks Inc., Natick, MA).
2.2.6. Assembly of ciproﬂoxacin with phospholipids by molecular
modeling using the Hypermatrix procedure
The Hypermatrix method described elsewhere [26] was success-
fully used to study the interaction between different molecules and
lipids [27–29]. In the Hypermatrix procedure, the lipid/water interface
was taken into account by varying linearly the dielectric constant ɛ
between 3 and 30.
The initial position and orientation of ciproﬂoxacin and of phospho-
lipids (DPPC and DPPG) were those deﬁned when using the TAMMO
procedure [26]. To obtain a multimolecular assembly of ciproﬂoxacin
and DPPC or DPPG with a 1:1 molar ratio, we ﬁrst carried out the
matching between one molecule of ciproﬂoxacin and one molecule of
lipid. For that, the position of the ciproﬂoxacin was set constant while
the lipid molecule was translated towards the ciproﬂoxacin molecule
along the x axis by steps of 0.05 nm. The lipid rotated by steps of 30
around its z′ axis and around the x axis. l was the number of positions
tested along the x axis, m was the number of rotations around
ciproﬂoxacin and nwas the number of rotations around the lipid itself.
For each set of l,m and n values, the energy of interaction between the
ciproﬂoxacin and the lipid was calculated as the sum of van der Waals,
electrostatic and hydrophobic terms [30]. Then, the lipid molecule was
moved by 0.01 nm step along the z′ axis perpendicular to the interface
and the angle between the z′ axis was bent by +1° with respect to the z
axis. The most stable ciproﬂoxacin:lipid complex was used in the next
step for the calculation of the multimolecular assembly. Following the
same procedure, one ciproﬂoxacin:lipid complex was set constant and
another 1:1 complex wasmoved towards it with the same combination
of rotations and translations than that described above. The energy
values together with the coordinates of all assemblies were stored in a
matrix and classiﬁed according to a decreasing order. The position of the
second complex corresponded to the most stable assembly in the
matrix. The position of the next 1:1 complex was then deﬁned as the
next most energetically favorable orientation stored in the matrix,
taking into account the steric and energy constraints due to thepresence
of the othermolecules. Theprocess endedwhen the central 1:1 complex
was completely surrounded.
An assembly of lipids alone was made following the same process,
with the central molecule being the lipid of interest. The mean area
occupied by one lipid or one ciproﬂoxacin molecule in the multi-
molecular complex or in the lipid assembly was estimated by
projection on the x–y plane using a grid of 1 Å2.
Pex2dstats ﬁles [31] were generated during the simulations and
allowed an easy and detailed analysis of each complex. All calculations
wereperformedonan Intel®Pentium®4,CPU3.80GHz, 4.00Goof RAM.
Fig. 2. Binding of ciproﬂoxacin to DPPG vesicles. Binding of ciproﬂoxacin to lipid vesicles
was followed by steady-state anisotropy in the presence of increasing amounts of DPPG.
The antibiotic concentration was 5 μM in Tris:NaCl buffer 10:100 mM (pH 7.4). The
continuous line corresponds to the ﬁt of the experimental points with Eq. (2) in order to
determine the binding constant. The stoechiometry of the interaction between
ciproﬂoxacin and lipids (inset) was performed in Tris buffer 10 mM (pH 7.4).
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3.1. Size and zeta potential of LUV liposomes
In order to characterize the homogeneity of the LUV liposomes
together with their surface charge, we investigated the size and zeta
potential of the liposomes used (DPPG, DOPC:DPPG, DOPC:DPPC and
DPPC). The results showed minor differences in the apparent mean
diameters of liposomes which were centered on 100 nm (DPPG
[124 nm], DOPC:DPPG [104 nm], DOPC:DPPC [92 nm], and DPPC
[101 nm]). As expected for negatively charged (DPPG) liposomes, the
zeta potential was more negative (−66 mV) than for DOPC:DPPG
(−34 mV), DOPC:DPPC (−6 mV) or DPPC (−5 mV) vesicles.
3.2. Binding of ciproﬂoxacin to LUV liposomes
As a ﬁrst step, to investigate the effect of ciproﬂoxacin on the lipid
membrane models, we checked the effect of increasing amounts of
ciproﬂoxacin on the size of the liposomes, by quasi-elastic light
scattering (Table 1). The ﬂuoroquinolone had no effect on the average
diameter of DPPC LUVs whatever the molar ratio investigated (Lipid:
drug ratios from 1:0.2 to 1:1). In contrast, for DPPG LUVs, the average
diameter increased with the increase of the ciproﬂoxacin concentra-
tion, reaching a value of 256 nm for a lipid:drug ratio of 1. The average
diameter was of 155 nm and 195 nm for a molar ratio of 1:0.2 and
1:0.5, respectively.
As a second step, we determined the binding constant, Kapp, by
adding increasing liposome concentrations to 5 μM ciproﬂoxacin in
10 mM Tris, 100 mM NaCl (pH 7.4) and following the steady-state
ﬂuorescence anisotropy. Fitting the experimental values according to
Scatchard equation (Fig. 2), Kapp values were close to 105 M−1
(Table 2). By comparing the afﬁnity of ciproﬂoxacin to DPPG liposomes
and DOPC:DPPG (1:1; M:M), it appeared that a decrease in the
concentration of negatively charged lipids (DPPG) in the liposome
mixture, led to a 2.5 fold Kapp value decrease. The critical effect of
DPPG on the interaction of ciproﬂoxacin was conﬁrmed by comparing
the Kapp values of DPPC versus those of DPPG (3.5 times lower) or
those of DOPC:DPPC versus those of DOPC:DPPG (3 times lower).
Taken together, our data showed that the ciproﬂoxacin bound to lipid
vesicles with the following preference: DPPGNDOPC:DPPG (1:1;
M:M)NDPPCNDOPC:DPPC (1:1; M:M). To get further data on the
binding between ciproﬂoxacin and lipids and to evaluate the
stoechiometry of this binding, we reproduced these experiments
in conditions in which NaCl was omitted. Saturation points for
ﬁtted binding curve approximately occur for lipids concentrations
equimolar to respective ligand concentrations suggesting a
stoechiometry of (1:1) (Fig. 2-insert). This was observed which-
ever the nature of the lipids investigated (DPPG or DPPC).
3.3. Effect of ciproﬂoxacin on the size and the mobility of phosphate
heads of DPPC and DPPG MLV's
From quasi-elastic light scattering studies and binding parameters,
the association of ciproﬂoxacin to lipids appears as strongly
dependent on the presence of the negatively charged phospholipid,
DPPG. To further explore this interaction, we measured by 31P NMRTable 1
Size of large unilamellar vesicles in the presence of increasing amounts of ciproﬂoxacin
as determined by quasi-elastic light scattering
Lipid:drug molar ratio Average size (nm)
DPPC DPPG
1:0 101±1 124±1
1:0.2 100±1 155±2
1:0.5 98±1 195±2
1:1 105±1 256±5spectroscopy the effective chemical shift anisotropy (Δσ) of the MLV
liposomes of DPPC and DPPG in the presence and in the absence of
ciproﬂoxacin at 45 °C. As shown in Fig. 3, typical spectra obtainedwith
multilamellar vesicles for both DPPC (top panel) and DPPG (bottom
panel) were characteristic of a bilayer organization with a high-ﬁeld
maximum and a low ﬁeld shoulder. In addition, the spectrum of 31P
NMR for DPPG revealed two peaks respectively at −10 ppm and 0 ppm.
The latter was probably due to the presence of a liposome population
(10%) of 150 nm of size as revealed by Nanosizer measurements.
Moreover, we observed a marked difference between the chemical
shift anisotropy (Δσ) value of DPPC as compared to that of DPPG, 41.5
and 25.5 ppm respectively. This can be related to themean diameter of
the major population of the MLVs which were 2100 nm for DPPC
(100%) and 1375 nm for DPPG (90%) vesicles.
In the presence of ciproﬂoxacin, the Δσ value was higher than that
of the control, for both types of liposomes. We obtained an increase of
the chemical shift anisotropy (Δσ) values of 5 and 9 ppm for DPPC and
DPPG, respectively. The presence of a population of larger size,
estimated around 5000 nm for DPPG vesicles and N10 μm for DPPC
vesicles could also be related to the difference observed in terms of
chemical shift anisotropy.
3.4. Effect of ciproﬂoxacin on the melting temperature of the lipids
As a sequel of the binding experiments, our further objective was
to determine the effect of the interaction between ciproﬂoxacin on
DPPC or DPPG on the melting behavior of the lipids.
To this end, we used ATR-FTIR spectroscopy. This method allowed
us the detection of the transition of the lipid hydrocarbon chains from
trans to gauche conformation which corresponds to the transition of
the lipid bilayer from gel (Lβ) to liquid-crystalline phase (Lα). It is
known that the absorbance of the peaks corresponding to theTable 2
Binding parameters obtained from steady-state anisotropy experiments
LUV liposomes composition Kapp (105 M−1)
DPPG 8.6±0.5
DPPC 2.5±0.1
DOPC:DPPG (1:1; M:M) 3.2±0.9
DOPC:DPPC (1:1; M:M) 1.1±0.2
Fig. 3. Effect of ciproﬂoxacin on 31P NMR spectra of multilamellar vesicles of DPPC (upper panel) and DPPG (lower panel). Liposomes (50 mg/ml) were prepared at pH 7.4 in 10 mM
Tris buffer. The experiments were performed at 45 °C. The chemical shift anisotropy (Δσ) values are indicated at the top of the spectra in the absence (a) and in the presence (b) of
ciproﬂoxacin added at a molar ratio of one.
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stretching bands are sensitive to the intramolecular vibrational
coupling and thus to the lateral packing of the hydrocarbon chains.
In order to determine accurately the peak maxima, a Gaussian line
was ﬁtted on the upper half of the position of the maximum for the
asymmetric CH2 stretching vibration (νas(CH2)) of DPPC (Fig. 4a) and
DPPG (Fig. 4b) vesicles and the result was plotted as a function of
temperature. Pure DPPC and DPPG vesicles (in Tris 10 mM, pH 7.4
buffer) exhibited a clear phase transition between the gel phase (Lβ)
and a liquid-crystalline phase (Lα). As expected, the DPPG melting
temperature is slightly lower than for DPPC (42 °C) and is near (40 °C).
The melting curve obtained for DPPC in the presence of
ciproﬂoxacin (Fig. 4a), showed a minor effect of the drug before and
after the main transition temperatures of DPPC since the frequencies
of the two dominant bands observed at 2917 (νas(CH2)) and 2849 cm−1(νs(CH2); not shown) were slightly below those observed for pure
DPPC. The melting temperature remained unchanged (42 °C).
In contrast, addition of ciproﬂoxacin to anionic lipid DPPG vesicles
induced a signiﬁcant change in themelting curve (Fig. 4b). Indeed, a net
positive shift of νas(CH2) stretching bands was observed at the pre-
transition temperature (between 20 and 37.5 °C). At a temperature
between 38 and 40 °C, the two bands centered at 2918 cm−1 (νas(CH2))
and 2850 cm−1 (νs(CH2); not shown) were signiﬁcantly changed. With
further increase in temperature (N40 °C), the peak positions of
stretching band remained signiﬁcantly below those of the pure DPPG.
These data suggest that the ciproﬂoxacin increased the membrane
ﬂuidity in the gel phase, as shown by the increase of the frequency of
νas(CH2) asymmetric vibration below Tm and decreased the membrane
ﬂuidity, notably in the liquid-crystalline phase (Lα), as shown by the
decrease the frequency of νas(CH2) asymmetric vibration above Tm.
Fig. 4. Evolution of themaximum frequency of the νas(CH2) as a function of temperature
for DPPC (a) or DPPG (b) in the absence (closed square ■) or in the presence (open
square□) of ciproﬂoxacin. The concentration of phospholipids was 50mg/ml. The lipid:
ciproﬂoxacin molar ratio was 1:1.
Fig. 5. Assembly of ciproﬂoxacin with DPPC (a) or DPPG (b) in a 1:1 molar ratio.
Ciproﬂoxacin is represented in Corey–Pauling–Koltum (CPK) mode, whereas the
phospholipids are in skeleton mode.
Table 3
Energy of interaction energy between lipid molecule and ciproﬂoxacin (CIP) and
molecular area of the lipid molecule at the interface
Energy of interaction (kcal/mol) Area (Å2)
DPPC/DPPC −30.5 63
DPPC/CIP −44.4 66
DPPG/DPPG −30.8 66
DPPG/CIP −53.4 76
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DPPC or DPPG
The interaction between ciproﬂoxacin and DPPC or DPPG at a (1:1)
molar ratio was calculated using the Hypermatrix procedure [26] as
described in the Materials and methods section. As shown in Fig. 5,
ciproﬂoxacin is inserted at the level of the phospholipid headgroup/
acyl chain interface for both lipids, as already suggested [1]. The
calculation of the interaction energy between DPPC or DPPG and
ciproﬂoxacin (Table 3) indicates that the association is more stable
with DPPG, the energy going from −44.4 kcal/mol for DPPC:
ciproﬂoxacin to −53.4 kcal/mol for DPPG:ciproﬂoxacin. Furthermore,
the presence of ciproﬂoxacin in DPPG signiﬁcantly increases the lipid
interfacial area, the DPPG value going from 66 Å2 in a monolayer to
76 Å2 in the calculated multimolecular assembly. The increase is less
important for DPPC, going from 63 Å2 for the lipid alone to 66 Å2 in the
assembly (Table 3).
4. Discussion
While numerous studies have shown a critical role of the porin
hydrophilic pathway for penetration of ﬂuoroquinolones through the
outer membrane of Gram-negative bacteria, the present work may
shed new light on their passage through the inner membrane of these
organisms (and through the membrane of Gram-positive bacteria) as
well as through the pericellular membrane of eukaryotic cells. In theabsence of demonstrated inward transporter, a direct interaction of
ﬂuoroquinolones with lipids allowing their diffusion through the so-
called hydrophobic pathway and/or self-promoted pathway must
indeed be considered critical for both the antibacterial activity
and the tissue distribution and cell accumulation properties of
ﬂuoroquinolones.
In order to gain further insight in the interactions of ﬂuoroquino-
lones with lipids, especially those found in bacterial membranes like
the negatively charged phospholipid phosphatidylglycerol, as com-
pared to the bulk lipids of eukaryotic membranes, phosphatidylcho-
line, we therefore determined (i) the binding parameters of
ciproﬂoxacin in interaction with these lipids using steady-state
ﬂuorescence anisotropy, (ii) the effect of ciproﬂoxacin on the mobility
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effect of ciproﬂoxacin on the acyl chain order as a function of
temperature using ATR-FTIR.
Steady-state anisotropy experiments showed that ciproﬂoxacin
binds to the lipid vesicles tested with a stoechiometry of 1 and a
moderate afﬁnity (105 M−1). This result is in agreement with the fair
hydrophobicity of ciproﬂoxacin and derivatives at neutral pH [6].
A partial selectivity (DPPGNDOPC:DPPG (1:1)NDPPCNDOPC:DPPC
(1:1)) was however evidenced. So, the greatest afﬁnity observed
with the negatively charged liposomes of DPPG or DOPC:DPPG
reﬂected the potential role of electrostatic interactions between
negatively charged phospholipid heads together with the H-bonding
[12,32–34]. This is in agreement with the results from quasi-elastic
light scattering which showed an effect of ciproﬂoxacin on the size of
DPPG liposomes whereas no effect was observed with DPPC. This is
also in accordance with the values of the energy of interaction as
calculated by molecular modeling. These calculations are based on a
semi-empirical force ﬁeld [30] that can be compared to experimental
values in terms of relative value (allowing a “ranking” of the different
molecules in terms of preferential interaction) but not in terms of
absolute value. The experimental interaction energy does not exactly
correspond to calculated values of binding energy since (i) the
calculated values depend on the energy force ﬁeld and (ii) solvation,
ionic strength, e.g. that contribute to the experimental measurements,
are not taken into account in the calculations. Interestingly, even
though the difference in the corresponding binding energy might be
less than 1 kcal/mol, it might result from a compensating compromise
between the enthalpy and the entropy of association as is often the
case for biological systems and regulations. The preferential role of
DPPG as compared to DPPC for the interaction between ciproﬂoxacin
and lipids has been also showed with other ﬂuoroquinolones like
grepaﬂoxacin [15] and oﬂoxacin [14] or with cyclic antimicrobial
peptides [35,36]. However, in accordance with literature [11–13] and
with calculations of the hydrophobic/hydrophilic environments of
ciproﬂoxacin/lipid complex using the Molecular Hydrophobicity
Potential (MHP), hydrophobic interactions could also play a critical
role in the interaction between ciproﬂoxacin and lipids. Indeed, such
computational analysis clearly revealed that most interactions are
hydrophobic whatever the nature of the lipid selected (unpublished
result). Because the main objective of the study is to shed light about
the peculiar interactions between ciproﬂoxacin and DPPG, a lipid
representative of bacterial membranes, on one hand and DPPC, a lipid
mimicking the mammalian membranes, on the other hand, the
relative contribution of electrostatic, hydrogen bonding, van der
Waals interactions… has not been further investigated in this work.
The potential role played by the nature of the phosphate
headgroup lead us to follow by 31P NMR, the chemical shift anisotropy
(Δσ) which depends on the local motions of the phosphodiester
moiety and its orientation. Below their Lα-liquid-crystalline phase
transition temperature, DPPG and DPPC in Lβ-gel phase produce both
an axially symmetric component and an asymmetric component
required to ﬁt their 31P spectra. When the temperature is raised above
the Lα-liquid-crystalline state phase transition value, the two static 31P
NMR components of the lipids collapse into a single axially symmetric
contribution. This dynamically averaged 31P NMR powder pattern
results from axial rotation of the phosphodiester moiety about the
bilayer normal, bond librations and overall lipid ﬂuctuations and
rotations [37]. Accordingly, the substantially smaller Δσ of the Lα state
compared to the Lβ state is attributed to the considerable decrease in
the correlation times of the 31P headgroup motions by more than one
to two orders of magnitude.
The Δσ value obtained for DPPC is similar to that reported in the
literature [38]. The lower value of the chemical shift anisotropy for
DPPG as compared to DPPC could be due to the size of the main
populations of DPPG liposomes (1375 nm) as compared to DPPC
liposomes (2100 nm) together with the presence of a populationsmaller liposomes of DPPG (centered on 150 nm). Unfortunately,
values obtained by quasi-light scattering showed a large variability
from onemeasurement to another which may be accounted for by the
fact that this type of measurement is strongly inﬂuenced by the
presence of small number of large vesicles [39].
Because rapid motions might exist for high curvature regions
or isotropic phases, therefore giving rise to a motionally averaged
isotropic chemical shift [40], the increase of Δσ values in the presence
of ciproﬂoxacin in interaction with DPPG, and in a lesser extent with
DPPC, suggested the appearance of such structures. Our results also
reﬂect the location of the ﬂuoroquinolone at the polar heads and near
the lipid–water interface [6,13]. The results that we obtained for the
interaction of ciproﬂoxacin with DPPC differ from those of Grancelli
et al. [13]. The latter reported a remarkable decrease of the second
spectral moment in solid state 31P NMR above Tm without modiﬁca-
tions below Tm, suggesting an enhancement of the mobility of the
headgroups of DPPC above Tm. At 45 °C, we observed an increase of Δσ
reﬂecting a decrease in the local mobility of the phosphate groups or a
reorientation of the phosphate moiety in the presence of the drug, in
accord with the binding of the drug to lipids. This discrepancy has not
yet received satisfactory explanations. A possibility could be found in
the preparation of the MLVs, and in the way the ciproﬂoxacin is added
to interact with lipids. This appeared as critical since when the DPPG
MLVs were prepared with the ciproﬂoxacin, we observed a precipita-
tion of the sample, which could be interpreted as revealing a very
strong electrostatic interaction between the negative charge of the
phosphate groups and the electric dipole moment of ciproﬂoxacin.
When ciproﬂoxacinwas added into the DPPGMLVs, themixture didn't
ﬂocculate, suggesting the probable existence of a metastable state
between both partners. This phenomenonwasn't observed in the case
of DPPC MLVs which are electrically neutral and possess an electric
dipole moment implying a softer electrostatic interaction with
ciproﬂoxacin.
At ﬁrst glance, the 31P chemical shift anisotropy variation upon
addition of ciproﬂoxacin into the DPPC and DPPG samples indicates
strongly that the drugs interact with the headgroups of the phos-
pholipids. Nonetheless, 31P magnetic relaxation dispersion measure-
ments would be necessary to describe more precisely the microscopic
details of the interactions and to know whether or not all the lipid
layers of the vesicles are involved and contact the ciproﬂoxacin
molecules.
To investigate further the effect of ciproﬂoxacin in interactionwith
lipids on the melting temperature of either DPPC or DPPG, ATR-FTIR
experiments were performed. Lipids can exist in several lamellar
phases depending on the temperature. For saturated phosphatidyl-
cholines, such as DPPC, there are four recognized lamellar phases;
namely, a liquid-crystalline phase (Lα), and phases with ordered
hydrocarbon chain arrangements: ripple phase (Pβ); gel phase (Lβ);
and subgel or crystal phase (Lc) [41]. The phase transition in lipid
bilayers involves a cooperative structural change from a state inwhich
the lipids are closely packed and their chains fully extended, to a state
in which a large fraction of the molecules exhibits as many gauche
rotations per molecule.
The frequencies of the CH2 stretching vibrations reﬂect the
order of the acyl chains. Highly ordered acyl chains with an all-trans
conformation as observed in the gel phase lead to lower vibrational
frequencies. With increasing fractions of gauche isomers and decreas-
ing van der Waals attractions in the liquid-crystalline phase the
absorption maxima of the stretching bands will be shifted to higher
frequency [42]. The results indicated that ciproﬂoxacin did not affect
dramatically the DPPC melting curve. However, we noted that
ciproﬂoxacin increased the order of the acyl chains both below and
above the transition temperature. This is in agreement with the ability
of ciproﬂoxacin to alter the tilt angle of the acyl chain of DPPC as
demonstrated previously by ATR-FTIR [1]. The slight effect of
ciproﬂoxacin on the order of the acyl chains of DPPC is in agreement
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known as hydrophobic quenchers, were able to quench the ﬂuores-
cence of ciproﬂoxacin in the presence of DPPC liposomes [34]. In
contrast, the effect of ciproﬂoxacin on DPPG ismajor. It was reasonable
to suggest that ciproﬂoxacin decreased the ordering of the acyl chain
of DPPG below the transition together with its ability to increase the
order above this temperature. These observations were similar to
those reported for cholesterol [43], a lipid well-known for broadening
the gel to ﬂuid transition temperature [44]. Moreover, our observa-
tions to compare the effect of ciproﬂoxacin on the frequencies of the
CH2 stretching vibrations of DPPC and DPPG are consistent with the
higher quenching of ciproﬂoxacin by iodide, in DPPC:DPPG as
compared to DPPC vesicles [45]. Surprisingly, however, no effect in
steady-state polarization of TMA-DPH as a function of temperature
was observed when ciproﬂoxacin was added to DPPC:DPPG as
compared to the effect on DPPC [45]. Further investigations have to
be done in this respect to explain this intriguing observation.
Globally speaking the major effect of ciproﬂoxacin on DPPG as
compared to the one on DPPC conﬁrmed the importance of the nature
of the polar heads of phospholipids. The role played by the
electrostatic interactions between ciproﬂoxacin and lipids has how-
ever to be conﬁrmed using other negatively charged lipids than DPPG,
like phosphatidylserine, cardiolipin, sulfatides, gangliosides [46]. The
ability of ciproﬂoxacin to interact with lipids through hydrogen
bonding and van der Waals interactions must also be investigated.
This would explain the mode of insertion of ciproﬂoxacin within the
lipids.
The binding parameters as determined by steady-state ﬂuores-
cence anisotropy were correlated with the mobility of phosphate
heads as determined by 31P NMR and the acyl chain order as
monitored by ATR-FTIR. Moreover, the increase of the area of DPPG
at the lipid–water interface as evidenced by conformational analysis
can be related to the local perturbations of the lipid bilayer observed
by 31P NMR which in turn may upset physiological properties of
membranes.
All our results support the existence of a primary step in a binding
of ciproﬂoxacin to the phospholipid bilayer surface and a possible
accumulation in enriched domains formed by negatively charged
lipids. This could allow the establishment of a concentration gradient
that would promote the diffusion of the drug through the bilayer.
This work thus provides new molecular insights in the interaction
between a ﬂuoroquinolone antibiotic, as a drug model, and lipids
mimicking those found in bacterial and eukaryotic membranes.
Finally, these results suggest that biophysical studies combined with
conformational analyses might be a powerful additional tool for the
characterization of the interactions between antibiotics and lipids.
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